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PURPOSE. Patients with diabetes mellitus are reported to have ocular surface defects,
impaired ocular surface barrier function, and a higher incidence of corneal and conjunc-
tival infections. Tight junctions are critical for ocular surface barrier function. The present
study was designed to investigate the effect of high glucose exposure on human corneal
and conjunctival epithelial cell barrier function and tight junction proteins.
METHODS. Human corneal and conjunctival epithelial cells were exposed to 15 mM and
30 mM glucose for 24 and 72 hours. The barrier function was measured using transep-
ithelial electrical resistance (TEER). The cell migration was quantified using scratch assay.
The cells were harvested for protein extraction and mRNA isolation. Gene and protein
expression of claudins, zonula occludens (ZOs), and occludin was quantified using real-
time PCR and Western blot.
RESULTS. Glucose caused a significant decrease in TEER after 72 hours of exposure in
both corneal and conjunctival epithelial cells. Glucose did not cause any notable change
in migration of either corneal or conjunctival epithelial cells. Glucose exposure did
not cause any notable change in protein expression of claudin-1, ZO-1, ZO-2, ZO-3,
or occludin. On the other hand, 15 mM glucose caused an increase in gene expression of
claudin-1, claudin-3, ZO-2, ZO-3, and occludin, a likely response to osmotic stress since
15 mM mannitol also caused consistently similar increase in gene expression of these
proteins.
CONCLUSIONS. High glucose exposure causes impairment of corneal and conjunctival
epithelial cell barrier function, but this detrimental effect is not caused by a decrease
in expression of tight junction proteins: claudin-1, ZO-1, ZO-2, ZO-3, and occludin.
Keywords: corneal epithelium, conjunctival epithelium, tight junction, high glucose,
diabetes mellitus
The ocular surface is perpetually exposed to the externalenvironment, which makes it vulnerable to microbes,
allergens, and chemicals. Corneal and conjunctival epithe-
lial cells form the outermost layer of the ocular surface and
provide a strong barrier against these environmental insults.
These cells have been shown to express components of tight
junction complexes.1,2 One of the major functions attributed
to the tight junctions is to restrict the paracellular move-
ment of large molecules and pathogens, thus significantly
contributing to the barrier function of epithelial cells.3–5
Tight junctions are localized on the apical-lateral surface of
epithelial cells and contain an assembly of integral trans-
membrane proteins that are further connected to the periph-
eral membrane proteins present in the cytosol. Four trans-
membrane proteins present in the tight junctions include
claudins, occludin, junctional adhesion molecule, and tricel-
lulin. The peripheral proteins are zonula occludens (ZO)–1,
ZO-2, and ZO-3, and they serve to connect the transmem-
brane proteins to the cytoskeletal proteins.3–5 The claudins
protein family consists of 27 members that share a common
feature of four transmembrane spanning regions forming
two extracellular loops and cytosolic C and N terminals.
Claudins demonstrate a tissue-specific distribution with vari-
ous combinations of the 27 subtypes being expressed in
the epithelial cells of various organs.6,7 Claudin-1, -2, -4, -
7, -9, and -14 expression has been detected in both human
corneal and conjunctival epithelial cells while claudin-3 and
claudin-10 were detected only in corneal epithelial cells
and conjunctival epithelial cells, respectively.1 Expression
of other components of tight junctions, including occludin
and ZOs, has also been detected in corneal and conjunctival
epithelial cells.1,2
Recent evidence suggests that diabetes mellitus has
many detrimental impacts on the anterior segment of
the eye, including tear film dysfunction, dry eye, corneal
keratopathy, and corneal epithelial defects.7–10 Abnormal-
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ities in epithelial cell density and maturation have also
been detected in the cornea of patients with diabetes
mellitus.11–13 Clinical studies using fluorometry-assisted
tracking of fluorescein penetration have consistently demon-
strated an impairment of corneal epithelial barrier func-
tion in diabetic patients showing a correlation between the
barrier impairment and HbA1c levels.14,15 In addition to
these corneal abnormalities, patients with diabetes melli-
tus have been reported to have conjunctival defects as well.
Abnormalities in conjunctival capillaries, including dilation,
increased tortuosity, and leakage, have been reported in
patients with diabetes mellitus.16,17 The incidence of infec-
tions in the conjunctiva and cornea of diabetic patients
is also higher compared with nondiabetics, suggesting a
compromise in the barrier function of the ocular surface
epithelium.18,19 Although many of these clinical studies have
consistently demonstrated diabetes-associated impairment
in the corneal and conjunctival barrier function, there are
no published data on how diabetes mellitus affects corneal
and conjunctival epithelial cell tight junction proteins. The
present study was designed to investigate the effect of high
glucose exposure on human corneal and conjunctival epithe-
lial cell barrier function and tight junction proteins: claudin-
1, ZO-1, ZO-2, ZO-3, and occludin.
MATERIALS AND METHODS
Human Corneal Epithelial and Conjunctival
Epithelial Cell Culture
Telomerase-transformed human corneal (provided by
Dr. James V. Jester, School of Medicine, University of
California, Irvine) and human conjunctival epithelial cells
(provided by Dr. Ilene Gipson, Harvard Medical School,
Boston, MA) were used for the experiments. The identity
of the cell lines was further confirmed by short tandem
repeats (STR) profiling from ATCC (Manassas, VA). The
human corneal epithelial cells were cultured in keratinocyte
growth medium supplemented with 4 μL/mL bovine pitu-
itary extract, 0.125 ng/mL human epidermal growth factor,
5 μg/mL insulin, 0.33 μg/mL hydrocortisone, 0.39 μg/mL
epinephrine, 10 μg/mL transferrin, and 0.15 mM calcium
chloride (PromoCell GmbH, Heidelberg, Germany).20,21
Human conjunctival epithelial cells were cultured
in keratinocyte serum-free medium supplemented with
25 μl/mL bovine pituitary extract, 0.2 ng/mL human epider-
mal growth factor, and 0.4 mM calcium chloride (Gibco,
Thermo Scientific, Rockford, IL).21,22
For high glucose treatment, the cells were exposed to
their respective growth media supplemented with 15 mM
and 30 mM glucose for 24 hours and 72 hours. Manni-
tol treatment was used to determine whether the observed
changes were due to the metabolic effects of glucose
or purely due to osmotic stress. For mannitol treatment,
cells were exposed to respective media supplemented with
15 mM and 30 mM mannitol for 24 hours and 72 hours. Each
experiment was conducted in triplicate.
Transepithelial Electrical Resistance
For measurement of transepithelial electrical resistance
(TEER), the cells were seeded onto collagen-coated 3.0-μm
polytetrafluoroethylene Costar transwell membrane inserts
(Corning, New York, NY) placed onto 12-well plates. The
cells were grown to produce confluent monolayer. The TEER
was measured using the chopstick electrode method by plac-
ing the electrodes on the top and bottom side of transwells
(Molecular Devices, San Jose, CA).
Scratch Assay
The cells were plated in 12-well plates. The scratch was
performed on the cells in two perpendicular straight lines
using a 1000-μL pipette tip. The dislodged cells were imme-
diately removed using media change. The cells were imaged
at the same position just above where the two perpendicu-
lar scratch lines intersected at time points immediately after
scratch (0) and then at 24, 48, and 72 hours using a phase
contrast lens on a bright-field microscope (Keyence BZ-X
710, Itasca, IL). The reepithelization of the scratch width
was quantified by measuring the distance between the two
edges of the scratch lines using ImageJ software (National
Institutes of Health, Bethesda, MD).
Isolation of mRNA and Preparation of cDNA
The total RNA from corneal and conjunctival epithelial cells
was isolated using a commercially available kit (RNeasy Mini
Kit; QIAGEN, Valencia, CA) as per manufacturer’s instruc-
tions. The RNAwas immediately reverse transcribed to cDNA
using a commercially available kit (SuperScript III First-
Stand; Invitrogen, Carlsbad, CA).
Gene Expression Quantification
The gene expression of the tight junction proteins claudin-1,
-2, -3; ZO-1, -2, -3; and occludin was quantified using real-
time PCR. The sequence of forward and reverse primers for
each of these target genes is listed in the Table. A 20-μL
reaction mixture containing 2 μL cDNA and 18 μL SYBR
Green Master Mix was run at a universal cycle (95°C for
10 minutes, 40 cycles at 95°C for 15 seconds, and 55°C for
60 seconds) using a QuantStudio 3 Real-Time thermocycler
(Applied Biosystems, Thermo Fisher Scientific, Singapore).
β-Actin was used as the housekeeping gene. The relative
change in gene expression was calculated using the Ct
method.
Immunoblotting
The protein extracts were prepared by adding radioim-
munoprecipitation assay (RIPA) buffer containing protease
inhibitor (Thermo Fisher Scientific, Rockford, IL) to the cells.
The cells were incubated in RIPA buffer on a shaker followed
by the removal of any adherent cells using a cell scraper. The
supernatant was collected as total cell lysate, and protein
concentration was determined by the BCA method using
a commercially available kit (Pierce BCA Protein Assay
Kit; Thermo Fisher Scientific). The protein extracts were
suspended in loading buffer containing β-mercaptoethanol
(Bio-Rad Laboratories, Carlsbad, CA) and heated at 95°C
for 5 minutes. Protein samples were resolved by loading
on 10% SDS-PAGE gels (Bio-Rad Laboratories) and run at
100 V for about 85 minutes using 1× TRIS-glycine-SDS
buffer. The resolved proteins were transferred from gel
onto the polyvinylidene difluoride membranes using wet
transfer at 100 V for 60 minutes. The membranes were
blocked in 5% blocking buffer and then incubated with
primary antibodies. The primary antibodies for human
claudin-1, -2, -3; ZO-1, ZO-2, ZO-3; and occludin were
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TABLE. Sequence of Forward and Reverse Primers Used for Real-Time PCR Quantification of Gene Expression
Gene Forward Primer Reverse Primer
Claudin-1 5’-CCA GTT AGA AGA GGT AGT GTG AAT-3’ 5’-CAG CCA GCT GAG CAA ATA AAG-3’
Claudin-2 5’-CCT CCA TCC CAC TCT TGT TAT G-3’ 5’-CAT CCT GCA TCC TGC TTT CT-3’
Claudin-3 5’-CCA AGG CCA AGA TCA CCA T-3’ 5’-GGT TGT AGA AGT CCC GGA TAA TG-3’
ZO-1 5’-GCA GCC ACA ACC AAT TCA TAG-3’ 5’-GAA AGG TAA GGG ACT GGA GAT G-3’
ZO-2 5’-AGG ATG CCG TTC TCT ACC T-3’ 5’-CAC AAG CCA GGA TGT CTC TAT AC-3’
ZO-3 5’-GGC GGG AAA GTT CAG TAG ATT-3’ 5’-GGC ACT CTG TAG ATG TCA TAG C-3’
Occludin 5’-GGA AGG TTC TGG TGT GAA CTA A-3’ 5’-CTG AAA GGT GGT TGA GAG GAT TA-3’
β-actin 5’-GGA CCT GAC TGA CTA CCT CAT-3’ 5’-CGT AGC ACA GCT TCT CCT TAA T-3’
purchased from Thermo Fisher Scientific. The membranes
were washed three times with 0.1% TBST (Tween 20 in Tris-
buffered saline), followed by incubation with donkey anti-
rabbit, horseradish peroxidase–conjugated secondary anti-
body (Abcam, Cambridge, MA).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as the housekeeping gene (Thermo Fisher Scien-
tific). The blot was developed using enhanced chemilu-
minescence reagents (Lumigen, Inc., Southfield, MI) and
imaged using a chemiluminescence gel imager (Bio-Rad
Laboratories). The digital quantification of Western blots was
performed by densitometric analysis using ImageJ software.
For each sample, the pixel density of the target protein band
was normalized by dividing it by the pixel density of the
corresponding GAPDH bands. The fold change was calcu-
lated by dividing the normalized target protein/GAPDH ratio
of test samples by the normalized target protein/GAPDH
band ratio of control samples. The respective control and
high glucose exposed samples for the corneal and conjunc-
tival epithelial cell extracts from the same gel were used for
comparison but have been rearranged in the figures to repre-
sent the data in a logical fashion. The Western blots were
run in triplicate. In separate pilot experiments, the valid-
ity of GAPDH as a housekeeping gene was confirmed by
comparing fold change in GAPDH compared with β-tubulin.
We did not detect any change in GAPDH protein expression
in cell extracts exposed to 15 mM or 30 mM high glucose
for 24 hours and 72 hours as compared with the control
samples cells exposed to media containing regular 5 mM
glucose. Three Western blots each for corneal and conjunc-
tival epithelial cells were performed for this validation (data
not shown).
Statistical Analysis
The data are presented as mean + SEM. Statistical analysis
was performed using GraphPad Prism software (version 8;
GraphPad Software, San Diego, CA). The data were analyzed
using two-way ANOVA, followed by Tukey’s post hoc test for
multiple comparisons. A P value of <0.05 was considered
statistically significant.
RESULTS
Effect of High Glucose on TEER
To test whether high glucose causes impairment of corneal
and conjunctival epithelial cell barrier functions, we cultured
a monolayer of the cells on a transwell membrane and
measured the TEER using the chopstick method. In human
corneal epithelial cells, 15 mM glucose caused 35% + 4%,
and 30 mM glucose caused 15% + 5% decrease in the TEER
after 72 hours of exposure, but no significant change in
TEER was observed after 24 hours (Fig. 1A). In conjunc-
tival epithelial cells also, 15 mM glucose caused 15% +
1%, and 30 mM glucose caused 8% + 1% decrease after
a 72-hour exposure but caused no notable effect after
24 hours (Fig. 1C). The decrease in TEER in both the cell
lines with the two tested concentrations noted only at 72
hours suggests that a persistent exposure to high glucose
may be required to cause impairment of barrier functions.
The more pronounced decrease of TEER noted in the corneal
epithelial cells suggests their likely higher susceptibility
to glucose-mediated detrimental effect compared with the
conjunctival epithelial cells.
In contrast to glucose, mannitol did not cause any
decrease in TEER in corneal epithelial cells at 72 hours, but a
significant decrease was noted after a 24-hour exposure with
the 15-mM dose only in corneal epithelial cells, suggesting
that these cells may be more sensitive to the moderate acute
osmotic stress caused by mannitol (Fig. 1B). Further, manni-
tol exposure did not cause any significant decrease in TEER
in the cultured conjunctival epithelial cells (Fig. 1D).
Effect of High Glucose on Cell Migration
Corneal and conjunctival epithelial cells migrate from limbus
to sclera and cornea. An impairment of epithelial cellular
migration can significantly compromise the barrier func-
tions. Therefore, we tested the effect of high glucose expo-
sure on the migration of corneal and conjunctival epithelial
cells. High glucose exposure did not affect the migration
of corneal epithelial cells (Fig. 2A) but caused a notable
albeit statistically insignificant increase in the migration
of conjunctival epithelial cells at the 30-mM concentra-
tion (Fig. 2C). On the other hand, mannitol at the 30-mM
concentration caused a statistically significant increase in the
migration of both corneal and conjunctival epithelial cells
(Figs. 2B, 2D).
Effect of High Glucose on Claudin Family Gene
and Protein Expression
Tight junctions play an important role in maintaining the
cellular barrier functions.3–5 The claudin family of proteins
is an integral part of tight junctions. Claudin-1 has high
expression in the corneal and conjunctival epithelial cells.1
Therefore, we next tested the effect of high glucose exposure
on the protein and gene expression of claudin-1. However,
Western blot data show that high glucose exposure for 24
or 72 hours did not cause any notable change in claudin-
1 protein expression in corneal epithelial cells (Fig. 3C) or
conjunctival epithelial cells (Fig. 3F). On the other hand, real-
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FIGURE 1. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on barrier function of corneal (A, B) and conjunctival (C, D)
epithelial cells quantified using TEER. *P < 0.05 compared to control (cells exposed to media containing no mannitol and regular 5 mM
glucose).
time PCR quantification of gene expression demonstrated
that glucose exposure caused a 2.33 + 0.4-fold increase
at 15 mM and a 1.88 + 0.3-fold increase at 30 mM in the
gene expression of claudin-1 in corneal epithelial cells after
72 hours (Fig. 3A). Glucose exposure at 15mM also caused
a 4.8 + 0.3-fold increase in claudin-1 gene expression in
conjunctival epithelial cells (Fig. 3D).
Mannitol also did not cause any notable change in
claudin-1 protein expression, and as was noted with glucose,
mannitol caused a significant increase in claudin-1 gene
expression in both cell lines after 72 hours (Figs. 3B, 3E).
Previous studies have reported the detection of claudin-2
and claudin-3 transcripts in human corneal and conjunctival
epithelial cells.1 Our data confirm these previous findings1
and demonstrate the presence of claudin-2 and claudin-
3 transcripts in human corneal and conjunctival epithelial
cells. Additionally, our data show that high glucose exposure
did not cause any notable change in the gene expression of
claudin-2 in human corneal and conjunctival epithelial cells
(Fig. 4, left panel). On the other hand, 15-mM glucose expo-
sure for 72 hours caused a 2.1+ 0.66-fold and 1.17+ 0.2-fold
increase in the gene expression of claudin-3 in corneal and
conjunctival epithelial cells, respectively (Fig. 4, right panel).
High mannitol exposure caused a significant increase in the
gene expression of both claudin-2 and claudin-3 in both the
cornel and conjunctival epithelial cells (Fig. 4). However,
Western blot quantification did not detect protein expression
of claudin-2 and claudin-3 in human corneal or conjunctival
epithelial cells, and our data are supported by a previous
report that did not detect claudin-2 and claudin-3 in human
corneal and conjunctival epithelial cells using immunostain-
ing.1
Effect of High Glucose on ZO Family Gene and
Protein Expression
The ZO family of proteins tethers the cytoplasmic chain of
claudin proteins to the cytoskeletal actin filaments.3–5 There-
fore, we next tested the effect of high glucose exposure on
the ZO family of proteins. Glucose exposure at either of the
tested concentrations did not modulate the ZO-1 gene or
protein expression in corneal (Figs. 5A, 5C) real time PCR
and conjunctival epithelial cells (Figs. 5D, 5F) as quantified
by Western blotting, respectively. Just like glucose, mannitol
also did not have any notable effect on the protein or gene
expression of ZO-1 in corneal (Figs. 5B, 5C) or conjunctival
epithelial cells (Figs. 5E, 5F).
Next, high glucose exposure did not modulate the protein
expression of ZO-2 also in either corneal (Fig. 6C) or
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FIGURE 2. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on cellular migration of corneal (A, B) and conjunctival (C, D)
epithelial cells quantified using scratch assay. *P < 0.05 compared to control (cells exposed to media containing no mannitol and regular
5 mM glucose).
conjunctival epithelial cells (Fig. 6F). However, 15 mM
glucose caused a 2.3 + 1.3-fold and 3.7 + 0.3-fold increase
in the gene expression of ZO-2 in corneal (Fig. 6A) and
conjunctival epithelial cells (Fig. 6D), respectively, after a
72-hour exposure. In congruence with the effects noted with
glucose, mannitol also did not cause any change in the
protein expression of ZO-2 but caused a notable increase in
the gene expression of ZO-2 in conjunctival epithelial cells
(Fig. 6E).
Lastly, high glucose did not cause any notable change
in the protein expression of ZO-3 as well in either corneal
(Fig. 7C) or conjunctival epithelial cells (Fig. 7F) but at a 15-
mM concentration did cause a 3.7 + 0.4-fold and 4.7 + 0.15-
fold increase in ZO-3 gene expression in corneal (Fig. 7A)
and conjunctival epithelial cells (Fig. 7D), respectively, after
a 72-hour exposure. As noted with glucose, mannitol
also did not cause any change in the protein levels of
ZO-3 but caused an increase in the gene expression of ZO-
3 in the corneal (Fig. 7B) and conjunctival epithelial cells
(Fig. 7E).
Effect of High Glucose on Occludin Gene and
Protein Expression
Just like claudin-1 and ZOs, high glucose did not cause any
significant change in occludin protein expression either in
corneal (Fig. 8C) or conjunctival epithelial cells (Fig. 8F),
but 15 mM glucose caused a 3.2 + 0.2-fold and 2.67 + 0.17-
fold increase in the gene expression of occludin in corneal
(Fig. 8A) and conjunctival epithelial cells (Fig. 8D), respec-
tively, after a 72-hour exposure.
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FIGURE 3. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on claudin-1 gene and protein expression in corneal (A–C)
and conjunctival (D–F) epithelial cells quantified using real-time PCR and Western blot. *P < 0.05 compared to control (cells exposed to
media containing no mannitol and regular 5 mM glucose).
FIGURE 4. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on claudin-2 (left panel) and claudin-3 (right panel) gene
expression in corneal and conjunctival epithelial cells quantified using real-time PCR. *P < 0.05 compared to control (cells exposed to media
containing no mannitol and regular 5 mM glucose).
Mannitol also did not affect the protein expression of
occludin in either cell line but caused a significant increase
in the gene expression of occludin in conjunctival epithelial
cells at a 15-mM concentration after 72 hours of exposure
(Fig. 8E).
DISCUSSION
Experimental diabetes mellitus and high glucose exposure
have been shown to cause an impairment of barrier func-
tion.23–29 A recent study reported a decrease in TEER in
human corneal epithelial cells exposed to 30 mM glucose.30
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FIGURE 5. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on ZO-1 gene and protein expression in corneal (A–C) and
conjunctival (D–F) epithelial cells quantified using real-time PCR and Western blot.
FIGURE 6. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on ZO-2 gene and protein expression in corneal (A–C) and
conjunctival (D–F) epithelial cells quantified using real-time PCR and Western blot. *P < 0.05 compared to control (cells exposed to media
containing no mannitol and regular 5 mM glucose).
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FIGURE 7. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on ZO-3 gene and protein expression in corneal (A–C) and
conjunctival (D–F) epithelial cells quantified using real-time PCR and Western blot. *P < 0.05 compared to control (cells exposed to media
containing no mannitol and regular 5 mM glucose).
FIGURE 8. Effect of glucose (15 mM; 30 mM) and mannitol (15 mM; 30 mM) on occludin gene and protein expression in corneal (A–C) and
conjunctival (D–F) epithelial cells quantified using real-time PCR and Western blot. *P < 0.05 compared to control (cells exposed to media
containing no mannitol and regular 5 mM glucose).
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Our data are in agreement with this report30 and addi-
tionally demonstrate that corneal epithelial barrier func-
tion can also be compromised by moderately high glucose
(15 mM). Furthermore, our results also show that high
glucose compromises human conjunctival epithelial cell
barrier function too. It is worth noting that both 15 mM
and 30 mM glucose caused an almost equivalent decrease
in TEER in both corneal and conjunctival epithelial cells but
only after 72 hours of exposure. These observations tenta-
tively suggest that the detrimental effects of high glucose
exposure are likely dependent on the duration of expo-
sure rather than the concentration. Corneal and conjunc-
tival epithelial cells are continually replenished by cells
migrating from limbus. A literature survey reveals that the
effect of high glucose exposure on corneal epithelial cell
migration is equivocal with studies reporting a delay, an
augmentation, or no change.30–32 Variables such as the use of
SV40, telomerase-immortalized, or primary cell types; inclu-
sion/exclusion of serum; and variable epidermal growth
factor (EGF) concentrations used in these studies likely
contribute to the reported equivocal effect of high glucose
exposure on corneal epithelial cell migration. However, our
data demonstrate that high glucose exposure does not signif-
icantly affect the migration of corneal or conjunctival epithe-
lial cells.
Tight junctions play a crucial role in maintaining cellu-
lar barrier function and are composed of claudins, occludin,
junctional adhesion molecule, and tricellulin.3–5 Corneal and
conjunctival epithelial cells have been shown to express
claudin-1, but protein expression of claudin-2 and claudin-
3 could not be detected in human corneal and conjuncti-
val epithelial cells.1 In accordance with these observations,
our results also show the presence of claudin-1 in corneal
and conjunctival epithelial cells but did not detect claudin-
2 and claudin-3 protein expression. The PDZ domains in
claudins interact with the intracellular ZO molecules, which
are further connected to cytoskeletal proteins for anchoring
function.6,7 Occludin in the tight junctions acts as a zipper to
hold the adjacent cells.33 Therefore, we tested whether alter-
ations in tight junction proteins claudin-1, ZOs, and occludin
may be responsible for high glucose–mediated impairment
of ocular surface epithelial cell barrier function. Qualitative
immunostaining data in a previous study show that high
glucose decreases ZO-1 protein levels in human corneal
epithelial cells. In contrast to this study, quantitative West-
ern blot analysis used in the present study demonstrated that
high glucose exposure does not cause any notable decrease
in ZO-1 in corneal or conjunctival epithelial cells. Besides
ZO-1, the present study is the first one to demonstrate that
high glucose exposure does not affect the protein levels of
claudin-1, ZO-2, ZO-3, and occludin in human corneal and
conjunctival epithelial cells. Therefore, a decrease in these
tested tight junction proteins does not seem the likely under-
lying cause for high glucose–mediated compromise of ocular
surface epithelial cell barrier function. Our data are further
supported by similar results noted in retinal pigmented
epithelial cells where high glucose caused a decrease in the
barrier function but without causing any change in claudin
or occludin proteins.29 Besides claudin-1, human corneal
and conjunctival epithelial cells have also been reported to
express other claudins such as claudin-4 and claudin-10.1 It
may be possible that a high glucose–mediated decrease in
claudin-4 or claudin-10 may contribute to the noted decrease
in barrier function and may be addressed by future studies.
The role of junctional adhesion molecule and tricellulin in
barrier functions of tight junctions is not completely under-
stood yet, it is possible that high glucose may impact these
proteins. Lastly, our study did not test the impact of high
glucose on the chemical or conformational changes of tight
junction proteins. Such alteration can also contribute to high
glucose–mediated compromise of barrier function without
causing any decrease in the protein levels.
In the current study, we also observed a highly consis-
tent increase in the gene expression of claudin-1, ZO-2,
ZO-3, and occludin in both corneal and conjunctival epithe-
lial cells when exposed to 15 mM glucose for 72 hours. This
observed increase in the gene expression of the tight junc-
tion proteins may be a compensatory cellular response to
mild or moderate osmotic stress since 15 mM mannitol also
caused consistently similar changes as observed with 15 mM
glucose. It is hard to explain why 30 mM glucose or mannitol
did not cause any increase in gene expression, but it may be
possible that high osmotic stress may initiate a diverse set
of compensatory responses.
In summary, the results of the present study demonstrate
that high glucose exposure causes impairment of corneal
and conjunctival epithelial cell barrier function, but this
detrimental effect is not caused by a decrease in the expres-
sion of tight junction proteins, including claudin-1, ZO-1,
ZO-2, ZO-3, and occludin.
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